The global pyrogen testing market size was valued at USD 1,348.3 million in 2021 and is poised to grow at a significant CAGR of 12.5% during the forecast period 2023-29. Chronic diseases are prevalent in highly developed nations and even more so in developing markets. Due to this, the need for pyrogen testing, as well as increased awareness, is predicted to develop rapidly throughout the projection period. North America should dominate the market share throughout the projection period due to the existence of well-developed healthcare organizations and well-defined laws and regulations for the pharmaceutical manufacturing process. Pyrogen testing is extremely useful in the evaluation of human-relevant airborne pyrogens in the case of airborne disorders such as chronic obstructive pulmonary disease and infantile asthma. These tests are also beneficial in identifying contamination caused by an inflammatory response in patients with chronic renal disease. Global Pyrogen Testing market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In May 2018, MilliporeSigma Announces Collaboration with Solvias, a Swiss contract research and service provider, to offer New Pyrogen Detection Kit.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/pyrogen-testing-market/
The global pyrogen testing market segmentation:
- By Product & Service: Assays Kits & Reagents, Instruments, Services
- By Test Type: LAL Tests, In Vitro Tests, Rabbit Tests
- By End-User: Pharmaceutical & Biotechnology Companies, Medical Device Companies, Other End Users
The increasing mortality rate due to chronic disease has boosted the need for an urgent requirement for speedy diagnosis, which has accelerated the expansion of the reagents and test kits segments. According to the Centers for Disease Control and Prevention, infectious diseases such as malaria, TB, and AIDS/HIV account for almost half of all fatalities globally. According to National Cancer Institute data, more than 1 million new cancer cases were documented in the United States in 2016. These cases are fast increasing each year and are predicted to cause more than 5 million cancer cases in the forecast years.
North America Leads Pyrogen Testing Market
North America is expected to hold a significant market share in the global pyrogen testing market and is projected to grow at a prominent growth rate over the forecast years due to its well-established healthcare infrastructure, superior regulatory framework, and the presence of biotechnological and biopharmaceutical companies across the regions North America is found to dominate the total market. Moreover, an increase in the frequency of chronic and infectious disorders across the Europe and Asia Pacific regions may significantly enhances the revenue of the market over the forecast years.
Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=61624
Key player’s profiles in the Pyrogen Testing Market report are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Associates of Cape Cod, Inc. (US), GenScript Biotech Corporation (China), bioMérieux SA (France), Eurofins Scientific (Luxembourg), WuXi AppTec (China), Hycult Biotech (Netherlands).
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174